0000911916-16-000699.txt : 20161205 0000911916-16-000699.hdr.sgml : 20161205 20161205163943 ACCESSION NUMBER: 0000911916-16-000699 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161201 FILED AS OF DATE: 20161205 DATE AS OF CHANGE: 20161205 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CoLucid Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001348649 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 203419541 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 781-365-2596 MAIL ADDRESS: STREET 1: 222 THIRD STREET CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Colucid Pharmaceuticals Inc DATE OF NAME CHANGE: 20060104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hogan Linda C. CENTRAL INDEX KEY: 0001639972 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37358 FILM NUMBER: 162034233 MAIL ADDRESS: STREET 1: 15 NEW ENGLAND EXECUTIVE PARK CITY: BURLINGTON STATE: MA ZIP: 01803 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-12-01 0001348649 CoLucid Pharmaceuticals, Inc. CLCD 0001639972 Hogan Linda C. C/O COLUCID PHARMACEUTICALS, INC. 222 THIRD STREET CAMBRIDGE MA 02142 0 1 0 0 Head, Bus. Dev. and Strategy Common Stock 2016-12-01 4 M 0 719 6.75 A 719 D Common Stock 2016-12-01 4 S 0 719 35.2191 D 0 D Common Stock 2016-12-05 4 M 0 186 7.56 A 186 D Common Stock 2016-12-05 4 S 0 186 38.75 D 0 D Common Stock 2016-12-05 4 M 0 1678 10.00 A 1678 D Common Stock 2016-12-05 4 S 0 1678 38.75 D 0 D Stock Option (Right to Buy) 6.75 2016-12-01 4 M 0 719 0 D 2026-03-04 Common Stock 719 27312 D Stock Option (Right to Buy) 7.56 2016-12-05 4 M 0 186 0 D 2025-08-04 Common Stock 186 5926 D Stock Option (Right to Buy) 10.00 2016-12-05 4 M 0 1678 0 D 2025-05-05 Common Stock 1678 48643 D Securities sold pursuant to a written plan intended to comply with Rule 10b5-1(c)(i) adopted by Ms. Hogan on March 24, 2016. Represents the sale of 719 shares in multiple transactions, ranging in price from $35.00 to $35.45 per share, resulting in a weighted average sale price of $35.2191. The reporting person will provide, upon request by the SEC staff, the Issuer or a security holder of the Issuer, full information regarding the number of shares sold at each price within the range. Options vest in a series of 48 successive equal monthly installments with the first monthly installment vesting on the grant date and the future installments vesting on the first day of each calendar month. Options vest as follows: one-third of the shares vested on August 4, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service. Options vest as follows: 33% of the shares vested on May 5, 2016; and the remaining shares vest in a series of 36 successive equal monthly installments upon completion of each additional month of service. /s/ Christine G. Long, Attorney-in-Fact for Linda C. Hogan (power of attorney previously filed) 2016-12-05